Business Context and Reporting Period
This Form 8-K filing by Genprex, Inc. (GNPX) is dated September 26, 2024. The report addresses a regulatory notice regarding the company's continued listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on compliance with listing standards.
Material Changes
The primary material event is the receipt of a notification from the Nasdaq Listing Qualifications Department. The Company is currently non-compliant with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of its Common Stock has remained below $1.00 per share for the last 30 consecutive business days.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has been granted an initial 180-day compliance period ending on March 25, 2025, to regain compliance.
- Path to Compliance: Compliance can be achieved if the closing bid price reaches at least $1.00 for a minimum of 10 consecutive business days during the initial period.
- Secondary Compliance Period: If the Company fails to regain compliance by March 25, 2025, it may be eligible for an additional 180-day period. This requires meeting other listing standards (e.g., market value of publicly held shares) and notifying Nasdaq of an intent to cure, potentially via a reverse stock split.
- Risks: There is no assurance the Company will regain compliance or secure a second period. Failure to cure the deficiency could result in delisting. The Company may appeal a delisting determination, but success is not guaranteed.
- Current Status: The notification has no immediate effect on the listing or trading of the Common Stock; the listing remains fully effective.
Investor Verification Checklist
- Verify the current closing bid price of GNPX stock relative to the $1.00 threshold.
- Monitor the company's stock price performance over the next 10 consecutive business days to assess immediate compliance potential.
- Review future filings for announcements regarding a potential reverse stock split if the initial compliance period expires without success.
- Check for any subsequent Nasdaq communications regarding the extension of the compliance period or delisting notices.